Cabazitaxel and Lupron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cabazitaxel (cabazitaxel) and Lupron (leuprolide acetate). Common drug interactions include malignant neoplasm progression among males.

The phase IV clinical study analyzes what interactions people have when they take Cabazitaxel and Lupron. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Cabazitaxel?

Cabazitaxel has active ingredients of cabazitaxel. eHealthMe is studying from 2,161 Cabazitaxel users. Check the latest studies of Cabazitaxel.

What is Lupron?

Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.

On Jul, 27, 2026

100 people who take Cabazitaxel and Lupron together, and have interactions are studied.

Cabazitaxel and Lupron drug interactions.

What are the common drug interactions of Cabazitaxel and Lupron, by gender? *:

female:

n/a

male:

Malignant neoplasm progression (cancer tumour came back)
Prostate cancer metastatic
Death
Disease progression
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Anaemia (lack of blood)
Diarrhoea
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Drug ineffective

What are the common drug interactions of Cabazitaxel and Lupron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)

50-59:

Anorectal disorder
Anxiety
Aortic arteriosclerosis (hardening of the aortic arteries)
Aortic dilatation
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthralgia (joint pain)
Ascites (accumulation of fluid in the abdominal cavity)
Atelectasis (partial or complete collapse of the lung)
Back pain
Benign gastrointestinal neoplasm (benign (non-cancerous) tumours of the gastrointestinal)

60+:

Malignant neoplasm progression (cancer tumour came back)
Metastases to bone (cancer spreads to bone)
Anaemia (lack of blood)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Decreased appetite
Nausea (feeling of having an urge to vomit)
Pulmonary oedema (fluid accumulation in the lungs)
Death
Asthenia (weakness)

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 32 people, 32.00%
Prostate Cancer: 32 people, 32.00%
Nausea (feeling of having an urge to vomit): 11 people, 11.00%
High Blood Pressure: 10 people, 10.00%
Stress And Anxiety: 7 people, 7.00%
Pain: 6 people, 6.00%
Nausea And Vomiting: 5 people, 5.00%
Insomnia (sleeplessness): 5 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cabazitaxel and Lupron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously